Leonard Stephen Marks, M.D.
Curriculum
Vitae
(current to September, 2007)
Table of
Contents Page
(s)
I.
General
& Formal Education . .
. . .
. . . . . .
1
II.
Honors,
Awards, Service . .
. . .
. . .
. . . . . 2-4
III.
Theses,
Lectureships, Committees, Consultancies 5-6
IV.
Peer-reviewed
Publications . .
. . .
. . .
. . . . 7-12
V.
Major
Presentations . .
. . .
. . .
. . .
. . . . . 13-19
Contact
Information: Leonard S. Marks, M.D.;
Phone:
310-559-9800 (24 hr); Fax: 310-559-7821; e-mail: lsmarks@ucla.edu
I.
GENERAL &
FORMAL EDUCATION
Place of Birth Houston,
Texas
Date of Birth April
15, 1944
Education
College Tulane
University
New
Orleans, Louisiana
Bachelor
of Arts with Honors, 1965
Medical School University
of Texas
Galveston,
Texas
Doctor
of Medicine (AOA), 1969
Graduate School University
of Texas
Galveston,
Texas
Master
of Arts (Physiology), 1969
Post Graduate Training
Intern in Surgery, 1969-1970 UCLA/Harbor
General Hospital
Torrance,
California
Resident in Surgery, 1972-1973 UCLA/Harbor
General Hospital
Torrance,
California
Resident in Urology, 1974-1978 University
of California
Los
Angeles, California
Fellowship, 1973-1974
Post-doctoral Research Scholar,
Department of Surgery, UCLA and Renal Hypertension Research Fellow,
Cedars-Sinai Medical Center Los Angeles, California.
II.
HONORS, AWARDS,
SERVICE
Educational Honors
Alpha Omega Alpha, 1969
Bachelor of
Arts with Honors, 1965
Awards
Associate Member, 2000 – 2002
Early Detection Research Network, Division of Cancer
Prevention, National Cancer Institute. “Free PSA Molecular Forms (BPSA &
proPSA): BIOMARKER ROLE.” In collaboration with the Brady Urological Institute
of Johns Hopkins University.
CapCURE
(Prostate Cancer Foundation) Research Award, 2000
"Biomarker
Expression in Benign and Malignant Prostate Tissues of Native Japanese and
Japanese-American Men"
American
Foundation for Urologic Disease Research Awards, 1993 & 1994
"Normalization
of Serum PSA levels in Men with Benign Prostatic Hyperplasia: Role of Prostatic
Epithelial Quantification"
Resident's Research Prize, 1976
Los Angeles Urological Society:
"Angiotensin Blockade in the Rapid Detection of Renovascular
Hypertension"
Clinical
Research Prize, 1976
Grayson
Carroll Essay Contest, American Urological Association: "Angiotensin Blockade
in Renovascular Hypertension: A
Controlled, Prospective Study"
Military
Service
Active Duty Lieutenant
Commander
Miscellaneous
State
Licensure
Board
Certification Diplomate, American Board of Urology
Year
of Election, 1980
University Affiliation
Department
of Urology
Clinical
Professor
Hospital Staff Appointments University
of
Los
Angeles, California
Brotman Medical Center
Culver
City, California
(Urology
Section Chief)
Current Directorships/Advisory Boards National BPH Registry
Sanofi-Synthelabo, Inc.
New
York, NY
Prostate
Cancer Advisory Board
Merck
& Company
Rahway,
NJ
BPH
National Advisory Board
GlaxoSmithKline
Research
Triangle Park, NC
Advisory
Council
Brotman Medical Center
Culver
City, CA
Founding
Director Urological Sciences Research Foundation
A
California Non-Profit Corporation
Los
Angeles, California
Associate Editorship Urology
(The Gold Journal)
Website
Editor
1998
- present
Website Director Urological
Sciences Research Foundation
1996
- present
Editorial Review Board Urology
(The Gold Journal)
1991
– present
III.
THESES,
LECTURESHIPS, COMMITTEES, CONSULTANCIES
Theses
1.
Marks,
L.S.: The effect of histamine shock on fibrinogen concentrations. University of
Texas Medical Branch Library, Galveston, Texas. Master of Arts Thesis
(Physiology), 1969.
2. Marks, L.S.: The effects of sensory
deprivation on electrical self-stimulation of the lateral posterior
hypothalamus.
Book Chapters
1.
Marks,
L.S.: Renovascular Hypertension. In Current Urologic Therapy, Kaufman, J.J.,
editor. W.B. Saunders Co., 1980. Philadelphia, pp. 156-160.
2.
Kaufman,
J.J., Marks, L.S., and Maxwell, M.H.: Renovascular Hypertension. In Surgery
Annual '79, Nyhus, L.M., editor.
Appleton-Century-Crofts, New York, pp. 313-361.
3.
Marks,
L.S. and Kaufman, J.J.: Renovascular Hypertension. In Urology, Karafin,L. and Kendall, A.R.
(eds.). Harper and Row, Hagerstown, Maryland, 1978.
Exhibits
"Diagnosis
and Treatment of Renin-Mediated
Hypertension" Marks, L.S., Kaufman,
J.J., and Maxwell, M.H. Presented at the American College of Surgeons, Dallas,
October, 1977; American Urological Association, Washington, D.C., May, 1978;
and American Medical Association, San Francisco, June, 1978.
Invited
Lectureships
1.
"The Interactive Journal: Multimedia will
Change Medical Publishing," Annual Conference of National Library of
Medicine/Association of American Publishers,
2.
“Dihydrotestosterone (DHT), The
Other Androgen. History and Clinical
Relevance Today,” Urology Grand Rounds Presentation,
3.
"Molecular Diagnosis of Prostate Cancer,"
House Cancer
4.
“5 alpha reductase
inhibition: history and clinical importance.”
Annual Meeting, Canadian Urological Association, Ottawa, Canada, July,
2005.
5.
“PCA3
Urine Test: Specificity and Improved Prostate Cell Recovery,” L.S. Marks, A.W. Partin, S. Brentano, et al. GORDON CONFERENCE, New Frontiers in Cancer
Detection and Diagnosis, Buellton, CA, Jan., 2005.
6. “The race against time: Issues surrounding andropause.” Annual Meeting, American Association of
Clinical Chemistry,
7. “BPH and Alpha-blockers, 2004: Alfuzosin, a new treatment.”
Annual Meeting, Academy of Managed Care Pharmacy, San Francisco, CA, April,
2004.
8. “Recent advances in PSA testing: development of
molecular forms.” Luminaries Dinner, Hybritech, Inc.,
Annual meeting, American Urological Association, 2001 (Orlando, FL) and 2002
(Chicago, IL).
9.
"Saw
Palmetto: Myth and Science." G. Raworth Williams
Lecture, Baylor University Hospital, Dallas, TX. March, 2001.
10. “Effect of Finasteride and Saw Palmetto
Extracts in Men with Symptomatic Benign Prostatic Hyperplasia.” 10th annual
Congress, Egresados de Los Urologo
de Centro Medico Nacional,
Governmental Committees
1.
Ad
hoc working group on PC-SPES, National Center for Complementary and Alternative
Medicine, S. Strauss, chmn, Washington, DC, 2003
2.
Scientific
Review Committee, “Alternative Therapies for BPH,” National Institute for
Diabetes, Digestive, and Kidney Diseases, N. Feder, chmn,
3.
National
Academy of Sciences Working Group on Saw Palmetto, Dietary Supplement report to
Food and Drug Administration, Allison Yates, chmn,
Urological Committee
American
Urological Association, Committee on Complementary and Alternative Medicine, F.Lowe, chmn, 2002-present.
Industrial Consultancies (1995 – present)
1.
Allergan,
2.
American
Medical Systems,
3.
Astellas,
4.
Bayer,
5.
Hybritech Division, Beckman Coulter Inc,
6.
Diagnostic
Ultrasound,
7.
Gen-Probe,
Inc.,
8.
GlaxoSmithKline,
9.
GTx,
Inc.
10. Indevus,
11. Light Science Oncology,
12. Lilly/ICOS,
13. Merck Research Labs,
14.
15. Onconome,
16. Pfizer, Inc.,
17. Sanofi-Synthelabo, Inc.,
18. Solvay Pharmaceuticals,
19. Tesera Pharmaceuticals,
20. Watson Pharmaceuticals,